Strategic partnerships Velico Medical is actively partnering with a wide range of blood centers, industry groups, and government programs to scale spray-dried plasma production and distribution. This presents a sales opportunity to align with their partner network and offer compatible equipment, services, or co-marketing that accelerates decentralized production at regional centers.

Decentralized PODs The collaboration with CRS Pharma to design containerized laboratory Pods enables mobile, scalable, on-site production of spray dried plasma at blood centers worldwide. Target this by offering turnkey pod integrations, consumables, maintenance packages, and reliable supply chains to support rapid deployment.

Federal funding Velico has attracted federal funding from the Department of Health and Human Services and related agencies. This signals potential budget cycles and procurement windows where enhanced storage, reconstitution, and transport capabilities for dry plasma could be funded or co-funded, creating opportunities for approved suppliers and service providers.

Clinical leadership With extensive transfusion medicine and trauma expertise and collaborations with trauma surgeons and emergency physicians, Velico sits at the intersection of clinical need and device deployment. Sales opportunities exist in clinician-focused trainings, on-site demonstrations, and integration with hospital emergency response workflows.

Scaling adoption Recent partnerships with major blood centers like STB&T, Versiti, and ImpactLife indicate aggressive expansion and educational programs around FrontlineODP and dry plasma products. A proactive approach is to deliver scalable programs, regional support, and volume-based pricing to support rapid adoption across multiple centers.